13. Multiple sclerosis/Neuromyelitis optica Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 3,340 Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

Multiple sclerosis/Neuromyelitis optica and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability